Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial

Primary Objective

This study plans to learn more about cannabidiol (CBD) as a potential treatment in patients that have Traumatic Brain Injury (TBI)-related symptoms. CBD is a chemical found in the cannabis (or hemp) plant that can be used as a medication.

Is this Study for You?

Let's Get Started!

Description

Our study is seeking individuals aged 18-60, who have been diagnosed with a traumatic brain injury (TBI). The goal of the study is to see whether cannabinoids (CBD) can improve TBI symptoms.

Main Procedures Involved: Main study tasks include blood draws, urine pregnancy and drug screening, questionnaires, and cognitive tests.

Duration of Participation: Your participation in this study will be 12 weeks, with 12 weeks of study medication use..

Details
Age

18 to 60 years

Eligibility

1. Between the ages of 18-60 2. Diagnosed with a traumatic brain injury (TBI) 3. Interested in using cannabidiol (CBD) for TBI symptoms

Compensation

220

Locations

Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Kent Hutchison,  PhD

Kent Hutchison, PhD

Study ID

Protocol Number: 22-1427

More information available at ClinicalTrials.gov: NCT05632627

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers